Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

Nanion launches HTS automated patch clamp platform

Nanion launches HTS automated patch clamp platform

Researchers report new way for creating tracers used with medical imaging

Researchers report new way for creating tracers used with medical imaging

Suppressing amygdala molecule enables faster recovery from PTSD symptoms

Suppressing amygdala molecule enables faster recovery from PTSD symptoms

Scientists develop new class of drugs to treat hereditary kidney disease

Scientists develop new class of drugs to treat hereditary kidney disease

Blood pressure drug appears to be helpful for people with Alzheimer's disease

Blood pressure drug appears to be helpful for people with Alzheimer's disease

Harvard chemists achieve landmark in drug discovery with synthesis of potent anti-cancer agent

Harvard chemists achieve landmark in drug discovery with synthesis of potent anti-cancer agent

Vitamin D metabolite may stop mechanism by which cancer cells become drug-resistant

Vitamin D metabolite may stop mechanism by which cancer cells become drug-resistant

Researchers develop new 3D tissue imaging technique to study disease at cellular level

Researchers develop new 3D tissue imaging technique to study disease at cellular level

New small drug-targeting molecules may improve cancer treatment

New small drug-targeting molecules may improve cancer treatment

Berkeley Lights and Amyris collaborate to improve testing of microbial strains

Berkeley Lights and Amyris collaborate to improve testing of microbial strains

Boehringer Ingelheim and University of Dundee extend collaboration to develop new cancer medicines

Boehringer Ingelheim and University of Dundee extend collaboration to develop new cancer medicines

Chemists build rich collection of natural product-like macrocycles for drug discovery

Chemists build rich collection of natural product-like macrocycles for drug discovery

Researchers find more effective way to treat drug-resistant cancers

Researchers find more effective way to treat drug-resistant cancers

Alzheimer's Drug Discovery Foundation announces first round of awards of Diagnostics Accelerator initiative

Alzheimer's Drug Discovery Foundation announces first round of awards of Diagnostics Accelerator initiative

Study uncovers how simpler organisms manage recycling of incomplete proteins

Study uncovers how simpler organisms manage recycling of incomplete proteins

Newly identified internal regulator helps control body's response to fight infection

Newly identified internal regulator helps control body's response to fight infection

Children's Tumor Foundation establishes significant research initiative to combat NF2

Children's Tumor Foundation establishes significant research initiative to combat NF2

New fluorescent sensor can detect migrating cancer cells

New fluorescent sensor can detect migrating cancer cells

Southern Research team aims to discover new, safer antimalarial medicines

Southern Research team aims to discover new, safer antimalarial medicines

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.